Nicotinamide Prevents Surgery-Induced Cognitive Decline in Aging Mice
NAD+ precursor protects against postoperative delirium by reducing inflammation and preserving brain plasticity in older mice.
Summary
Researchers found that nicotinamide (vitamin B3) prevents cognitive decline and brain dysfunction caused by bone fracture surgery in aging mice. The supplement reduced neuroinflammation, preserved synaptic plasticity, and maintained memory function when given before and after surgery. This suggests NAD+ metabolism plays a crucial role in postoperative delirium, a common and dangerous complication affecting up to 53% of older surgical patients that increases mortality and healthcare costs.
Detailed Summary
Postoperative delirium affects up to 53% of surgical patients, particularly those over 65, causing acute cognitive dysfunction, increased mortality, and long-term cognitive decline. Despite its devastating impact, no established treatments exist due to limited understanding of underlying mechanisms.
Researchers used 20-22 month old female mice undergoing tibial fracture surgery to model human hip fractures, a common cause of postoperative delirium in elderly patients. Mice received nicotinamide (300mg/kg) or saline for 5 days before surgery and 3 days after, then underwent comprehensive testing 72 hours post-surgery.
Surgery dramatically impaired brain function: long-term potentiation (a measure of synaptic plasticity) decreased, dendritic spine density dropped, and hippocampal-dependent memory declined significantly. Inflammatory markers IL-1β and CD38 increased while neuroprotective BDNF decreased. Nicotinamide pretreatment prevented all these changes, maintaining normal cognitive function and brain plasticity.
The protective mechanism appears to involve NAD+ metabolism and the CD38 signaling pathway. Surgery increased oxidative stress in calcium channels and disrupted cellular energy metabolism, while nicotinamide supplementation restored normal NAD+ levels and reduced neuroinflammation.
These findings suggest that age-related NAD+ decline makes older adults vulnerable to surgery-induced cognitive dysfunction, and that nicotinamide supplementation could offer a simple, safe intervention. However, translation to humans requires clinical trials to establish optimal dosing, timing, and safety profiles in surgical populations.
Key Findings
- Nicotinamide prevented surgery-induced cognitive decline and memory impairment in aging mice
- Treatment preserved synaptic plasticity and dendritic spine density in hippocampus
- Supplement reduced neuroinflammation markers IL-1β and CD38 while maintaining BDNF levels
- Protection occurred through NAD+ metabolism and CD38 signaling pathway modulation
- Effects suggest potential therapeutic target for postoperative delirium prevention
Methodology
Controlled study using 20-22 month old female C57BL/6J mice with tibial fracture surgery model. Comprehensive assessment included electrophysiological recordings, behavioral testing, molecular analysis, and histological examination 72 hours post-surgery.
Study Limitations
Single-sex mouse model may not reflect human diversity. Optimal dosing, timing, and safety in human surgical populations requires clinical validation. Long-term cognitive outcomes beyond 72 hours not assessed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.